AAAAAA

   
Results: 1-8 |
Results: 8
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer
Authors: Skovsgaard, T Davidson, NGP Piccart, MJ Richel, DJ Bonneterre, J Cirkel, DT Barton, CM Knight, S
Citation: T. Skovsgaard et al., A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer, ANN ONCOL, 12(9), 2001, pp. 1255-1257
Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
Authors: Ryberg, M Nielsen, D Osterlind, K Skovsgaard, T Dombernowsky, P
Citation: M. Ryberg et al., Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy, ANN ONCOL, 12(1), 2001, pp. 81-87
Expression of P-glycoprotein associated protein in Ehrlich fractionated and multidrug resistance ascites tumor cells after irradiation
Authors: Nielsen, D Maare, C Eriksen, J Litman, T Skovsgaard, T
Citation: D. Nielsen et al., Expression of P-glycoprotein associated protein in Ehrlich fractionated and multidrug resistance ascites tumor cells after irradiation, INT J RAD O, 51(4), 2001, pp. 1050-1057
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
Authors: Nielsen, D Dombernowsky, P Larsen, SK Hansen, OP Skovsgaard, T
Citation: D. Nielsen et al., Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study, CANC CHEMOT, 46(6), 2000, pp. 459-466
Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide
Authors: Nielsen, D Maare, C Eriksen, J Litman, T Friche, E Skovsgaard, T
Citation: D. Nielsen et al., Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide, BIOCH PHARM, 60(3), 2000, pp. 353-361
Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascitestumour cells selected for resistance to mitoxantrone
Authors: Nielsen, D Eriksen, J Maare, C Litman, T Kjaersgaard, E Plesner, T Friche, E Skovsgaard, T
Citation: D. Nielsen et al., Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascitestumour cells selected for resistance to mitoxantrone, BIOCH PHARM, 60(3), 2000, pp. 363-370
Enhancement of cytotoxicity by electropermeabilization: an improved methodfor screening drugs (vol 9, pg 319, 1998)
Authors: Gehl, J Skovsgaard, T Mir, LM
Citation: J. Gehl et al., Enhancement of cytotoxicity by electropermeabilization: an improved methodfor screening drugs (vol 9, pg 319, 1998), ANTI-CANC D, 10(10), 1999, pp. 929-929
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution
Authors: Gehl, J Sorensen, TH Nielsen, K Raskmark, P Nielsen, SL Skovsgaard, T Mir, LM
Citation: J. Gehl et al., In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution, BBA-GEN SUB, 1428(2-3), 1999, pp. 233-240
Risultati: 1-8 |